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Abstract
Background: African Trypanosomiasis is a neglected tropical disease with a large impact on the livelihood of
the rural poor in Sub-Saharan Africa. The available drugs for managing this disease are old, expensive and are
facing the problem of drug resistance. Thus, the aim of this study was to evaluate in vivo antitrypanosomal
efficacy of aqueous and absolute methanol leaf extracts of Verbascum sinaiticum Benth. against Trypanosoma
congolense field isolate.
Methods: Verbascum sinaiticum (Local name ‘qetetina’) is a biennial plant, and 60–150 cm tall. It is traditionally
used to treat wound, stomachache, viral infection, cancer, sunstroke, fever, abdominal colic, diarrhea,
hemorrhage, anthrax, and hepatitis. The efficacy of aqueous and absolute methanol leaf extracts of V. sinaiticum
was evaluated in a randomized experiment with Swiss albino mice infected with T. congolense field isolate. The
extracts were administered at doses of 100, 200 and 400 mg/kg by intraperitoneal injection for seven days at 12
Days Post-Infection (DPI) when the peak parasitaemia level was approximately 108 trypanosomes/ml.
Parasitaemia, Packed Cell Volume (PCV), mean survival time and change in body weight were used as indices for
monitoring the efficacy of the extracts. Diminazene (28 mg/kg) was used as a positive control while 2 % Tween
was used as the negative control. Phytochemicals screening were conducted following standard methods.
Results: The extracts showed no toxicity effect in Swiss albino mice and had LD50 above 2000 mg/kg. The
phytochemicals screened in V. sinaiticum were alkaloids, flavonoids, glycoside, saponins, steroids, phenolic
compounds, and tannins. The mice treated with absolute methanol leaf extract of V. sinaiticum at 400 mg/kg
dose had significantly lower mean parasitaemia (7.20 ± 0.16) (p < 0.001) as compared to the negative control
group (8.82 ± 0.12) on day 14 of treatment. Animals treated with the same dose had significant (p < 0.001) higher
PCV value and body weight and as well as the highest mean survival time of 40.20 ± 0.31 days as compared to
the negative control at the end of the observation period.
Conclusion: This study established that Verbascum sinaiticum had trypanocidal activity. The crude extracts have
partially eliminated trypanosomes in a dose-dependent manner. The study can be a basis for future in-depth
analysis of the biologically active chemicals.
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Background
African Animal Trypanosomiasis (AAT) is a neglected
tropical disease caused by Trypanosoma brucei brucei, T.
vivax, and T. congolense while human Trypanosomiasis
is caused by two subspecies of Trypanosoma brucei: T.
brucei gambiense, and T. brucei rhodesiense [1, 2]. The
disease has an enormous economic impact in Africa
since it affects the settlement patterns of people including
land use and farming [3, 4]. In Ethiopia, AAT is one of the
most significant and costly diseases because it hinders the
effort made by the government to attain food sufficiency
and affect the greater river basins of Abay, Omo, Ghibe,
and Baro that have a high potential for agricultural devel-
opment [5–8].
Trypanocides are used for the control of the disease in
37 African countries where animal trypanosomiasis is
endemic but the available drugs are old, expensive, less
effective, and face the problem of drug resistance [9–11].
The continued use of the same Trypanocides for years
has resulted in drug resistance that has been largely re-
sponsible for the current chemotherapeutic failures in
Ethiopia [9, 12]. Therefore, there is a need to develop alter-
native and efficacious drugs, either synthetically or from
plant origins.
Herbal remedies are known to have been used for the
treatment of this disease such as. Khaya senegalensis,
Piliostigma reticulatum, Securidaca longepedunculata,
Ximenia americana and Artemisia abyssinica [2, 13, 14]
and are strongly trypanocidal to T. b. brucei and T. con-
golense. In Ethiopia, recent reports indicated that some
medicinal plants have antitrypanosomal activity and the
potentials of many of these plants are yet to be investi-
gated and claims to be tested [15–19]. Thus, this study
was designed to determine the in vivo antitrypanosomal
activity of V. sinaiticum against T. congolense infected
mice. This study will also seek to validate results from
the previous study by Mergia et al. [20] that gave indica-
tions of in vitro antitrypanosomal activity of methanol
crude leaf extracts of V. sinaiticum against T. congolense
field isolate.
Verbascum sinaiticum is traditionally used as a treatment
for wound, stomachache [21]; viral infection, cancer [22];
sunstroke fever, abdominal colic, diarrhea, hemorrhage, an-
thrax [23]; hepatitis; and as hepatoprotective [24, 25].
Moreover, powder leaf of V. sinaiticum mixed with water
is given orally [22, 26] and the filtrate is added to left
ear and nose of animals [23] for the treatment of animal
trypanosomiasis. The species in genus Verbascum are
well-known drugs in folk medicines.
Methods
Reference drug and chemicals
The commercial trypanocidal drug used was dimina-
zine aceturate (Veriben® containing 1.05 g diminazine
aceturate + 2.36 g antipyrine, (Ceva Santé Animale,
France; batch number- 719A1).
Plant material
Collection of plant specimen
Voucher specimens and fresh leaves of V. sinaiticum were
collected, in March 2013, from Entoto-mountain about
10 km north of Addis Ababa, Ethiopia. The taxonomic
identification was done by an expert using Taxonomic
keys and herbaria samples and deposited (Collection
EM/002) at the National Herbarium of Addis Ababa
University. The fresh leaf samples were prepared by air
drying, grinding, and kept in plastic bags until required.
Preparation and storage of extracts
The aqueous and absolute methanol extracts were pre-
pared by macerating 200 g of dried leaf powder of V.
sinaiticum with 1000 ml of each solvent for 48 h. After
filtering using Whattman No. 3 filter paper (Whattman
Ltd., England), the aqueous extract was placed on a Petri
dish and lyophilized for seven days to yield a solid residue.
The absolute methanol extract was dried using Rotavapor
(BÜCHI Rotavapor, Switzerland) at about 40 oC. The dried
and powder samples of each were weighed and packed in
glass vials and stored in desiccators over silica gel until re-
quired for use. The percentage yield was calculated as:
Percentage yield ¼ Amount of extract obtained
Amount of initial sample
 100%
Phytochemical screening
Aqueous and absolute methanol extracts of V. sinaiticum
were screened for the presence of phytochemical following
standard methods: alkaloids, phenolic compounds [27, 28],
Anthraquinones [29], flavonoids [30], glycoside, saponins,
tannins [31], Steroids, and terpenes [32].
Study site selection and test organism
The selection of the study site was based on the informa-
tion from the National Tsetse and Investigation and Con-
trol Centre (NTTICC), and the National Animal Health
Diagnostic and Investigation Center (NAHDIC) located in
Bedele town, and previous reports on the prevalence of
animal trypanosomiasis in the area [20, 33–35]. The test
organism, T. congolense was acquired from infected cattle
at Sebategna kebele of Ilu-Aba-Bora-Zone, 480 km South
West of Addis Ababa where the cattle in this area are
known for drug resistance in cattle. However, the sensitiv-
ity of the test organism to existing drugs was not known.
The blood sample was collected by NTTICC expert from
the peripheral ear vein of each animal following the
methodology in Mergia et al. [36]. The presence of T.
congolense was detected by Microhaematocrit Buffy
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Coat Technique (MHBCT) [37] and Murray et al. [38].
Blood from the jugular vein of an animal with peak
parasitaemia of (~108 trypanosomes/ml) [39] was col-
lected to the ethylene diamine tetra acetic acid (EDTA)
coated tube and diluted with PBS. Then 0.2 ml of blood
(~104 trypanosomes/ml) was injected intraperitoneally to
six laboratory mice and transported to Aklilu Lemma In-
stitute of Pathobiology, Addis Ababa University for serial
passage to other mice. About 0.2 ml of blood collected
from the donor mice containing (~104 trypanosomes/ml)
[39] was injected intraperitoneally into mice that were
acclimatized to laboratory conditions and were used for
in vivo evaluation of the crude leaf extracts of V. sinai-
ticum [36].
Experimental animals
Healthy Swiss albino mice (weighing 20–30 g and age of
8–12 weeks) were obtained from the Ethiopian Health
and Nutrition Research Institute and School of Pharmacy,
Addis Ababa University. Animals were housed in polypro-
pylene cages (6–10 animals per cage), maintained under
12 hr light/dark cycle and allowed free access to a pellet diet
and clean water ad libitum. All procedures comply with the
guide for the care and use of laboratory animals [39–41].
Determination of acute toxicity
The acute toxicity study was conducted in two phases,
each with nine female Swiss albino mice. After seven days
of adaptation, each extract, aqueous and methanol was
dissolved in 2 % Tween 80 in sterile water and given
through intraperitoneal route. In the first phase, three
groups, each with three mice were given 10, 100, and
1000 mg/kg body weight of doses of each extract, respect-
ively. In the second phase, three mice within each group
were given 1600, 2900, and 5000 mg/kg doses of each ex-
tract, respectively to determine the appropriate lethal dose
(LD50) value. Also, a third group of six mice (three mice
for each phase) was set up as a control group and received
the reconstituting solvent 2 % Tween 80 in sterile water.
All animals were kept under strict observation for behav-
ioral, neurological, autonomic or physical changes such as
alertness, motor activity, restlessness, convulsions, coma,
diarrhea and lacrimation for 24 h, with special attention
during the first four hours. These observations continued
for further 14 days for any signs of overt toxicity. Then
the lowest dose, which killed one mouse (minimum toxic
dose) and the highest dose, which had not killed any
mouse (maximum tolerated dose) were noted, and the
geometric mean of these two doses gave LD50. The LD50
was computed using the formula:
LD50 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Minimum Toxic Dose Maximum Tolerated Dose
p
Determination of in vivo antitrypanosomal
activities
Parasite inoculation and extracts administration
Forty healthy Swiss albino mice infected intraperitone-
ally with 0.2 ml of T. congolense infected blood (~104try-
panosomes/ml) were used to test trypanocidal activities of
aqueous and methanol extracts. The mice were randomly
divided into eight groups each comprising of 5 mice. The
treatment of mice with the extracts in each group began
on the 12th day of post-infection (day 0 of treatment) when
the infected mice showed peak parasitaemia (~108 try-
panosomes/ml). Group I-III were given V. sinaiticum
aqueous extract (VSAE) of 100, 200, 400 mg/kg; group IV-
VI were given V. sinaiticum methanol extract (VSME) of
100, 200, 400 mg/kg, respectively. The positive control,
group VII was treated with diminazine aceturate (Veriben®)
(DA28) at a single dose of 28 mg/kg bwt while for the
negative control, group VIII was given 2 % Tween 80
(TW80). On each day of drug administration, the aqueous
and methanol extracts of V. sinaiticum were freshly pre-
pared by solubilizing in 2 % Tween-80 in sterile water and
administered intraperitoneally in the morning consecu-
tively for seven days. The doses were selected based on the
acute toxicity study. The middle dose was one tenth of the
lethal dose (~2000 mg/kg), higher dose was twice the mid-
dle dose, and the lower dose was half of the middle dose
[41].
Determination of parasitaemia
A drop of blood obtained from a mouse by tail snipping
was used to make smears on the slides and to monitor
parasitaemia every other day microscopically at 400× total
magnification. The degree of parasitaemia was determined
using the “Rapid Matching” method of Herbert and
Lumsden [38]. The wet smear was prepared in triplicates
from each animal, and the mean value of slide counts was
taken per sample examined microscopically. Logarithm
values of these counts were obtained by matching with
the table given by Herbert and Lumsden [38].
% change in parasitemia
¼ Mean parasitemia on DAY 14−Mean Parasitemia on DAY 0
Mean Parasitemia on DAY 0
 100
Determination of packed cell volume (PCV)
Packed cell volume was measured using Wintrobe and
Landsberg [42], and Wernery et al. [43] methods to pre-
dict the effectiveness of the test extracts in preventing
hemolysis resulting from increasing parasitaemia asso-
ciated with trypanosomiasis. It was monitored for infec-
tion three times until the 14th day (on day 0, 7, 14). 12
DPI was an important day to monitor since the treat-
ment of mice with the extracts in each group began on
the 12th day of post-infection (day 0 of treatment)
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when the infected mice showed peak parasitaemia
(~108 trypanosomes/ml). The effect of extracts in improv-
ing the PCV of treated animals was compared with the
controls.
% change in PCV
¼ Mean PCV on DAY 7−Mean PCV on DAY 0
Mean PCV on DAY 0
 100 and on 14DPI?
Determination of body weight
The body weight (in gram) of each mouse in all groups
was measured before infection, on the day treatment com-
menced (day 0) and every other day (on Day 2, Day 4, Day
6, Day 8, Day 10, Day 12 and Day 14) up to day 14.
% change in Body weight
¼ Mean body weight on Day 14−Mean Body weight Day 0
Mean Body weight on Day 0
 100
Determination of mean survival time
Mortality was monitored daily and the number of days
from the date of inoculation of the parasite to death was
recorded for each mouse in the treatment and control
groups throughout the follow-up period for six weeks.
The Mean Survival Time (MST) for each group was cal-
culated as follows;
Mean survival time ¼ Sum of survival time of all mice in a group daysð Þ
Total number of mice in that group
Data analysis
The data obtained from the study were summarized and
expressed as mean ± standard error of mean (SEM). Data
analysis was performed using Statistical Package for Social
Science (SPSS), version 17.0. One-way ANOVA followed
by Tukey’s multiple comparison tests were carried out to
compare the results obtained from different groups and to
determine statistical significance. P values less than 0.05
were considered significant.
Results
Yield for plant extract and phytochemical screening
The aqueous and methanol leaf extracts of V. sinaiticum
gave 13.09%w/w and 18.13%w/w respectively. The phyto-
chemical screening results are shown in Table 1. The
methanol extract had more phytochemicals compared to
the aqueous extract; however, anthraquinones and terpenes
were absent in both extracts.
Acute toxicity test
The acute toxicity bioassay showed that the Lethal
Dosage (LD50) of the aqueous (LD50 = 3807.9 mg/kg)
and methanol (LD50 = 2154.1 mg/kg) leaf extracts of V.
sinaiticum was above 2000 mg/kg and there was no
evidence of an acute toxicity at the doses tested indicating
good safety margin.
In vivo antitrypanosomal activity of aqueous and
methanol crude extracts
Effect on parasitaemia
The reduction of parasitaemia showed variation among
the administered doses of aqueous and methanol extracts
of V. sinaiticum. The animals treated with 400 mg/kg dose
of the aqueous extract had significantly (p < 0.001) low
level of parasitaemia on days 8 and 10 when compared
with other doses of the aqueous extract treated mice. The
methanol leaf extract of V. sinaiticum at 100 mg/kg,
200 mg/kg and 400 mg/kg had kept parasitaemia at a sig-
nificantly low level on day 6, 8, 10, 12 and 14 (p < 0.001)
as compared with the negative control (Table 2).
Effect on packed cell volume
Animals treated with a higher dose (400 mg/kg) of the
aqueous extract of V. sinaiticum had a statistically sig-
nificant (p < 0.001) higher PCV value (47.14 ± 0.25) as
compared to the negative control group (40.58 ± 0.28)
on day 14 of treatment. Analysis of change in the per-
centage of PCV from day 7 to day 14 of treatment also
showed that the aqueous extract at 200 and 400 mg/kg
dose had prevented a drop in PCV associated with try-
panosomes as compared to the negative control group
(Table 3). In consistence with the results seen in PVC
(Fig. 1), animals treated with the methanol extract of V.
sinaiticum had higher PCV value (p < 0.001) as compared
to the negative control groups at the end of the observa-
tion period (Table 3).
Effect on body weight
The aqueous and methanol extracts of V. sinaiticum were
capable of improving body weight of treated animals on
days 8–14 as compared to the negative control group
Table 1 Phytochemicals screened from the aqueous and
methanol leaf extracts of Verbascum sinaiticum
Constituents V. sinaiticum







Phenolic compounds - +
Tannins - +
Terpenes - -
+ = present, - = absent
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(p < 0.001). Animals treated with 400 mg/kg dose of
both extracts of V. sinaiticum had a significantly (p <
0.001) higher body weight as compared to the negative
control group (19.09 ± 0.34) on day 14 of treatment
(Fig. 2).
Effect on mean survival time
Animals treated with 400 mg/kg of the methanol extract
of V. sinaiticum had the highest mean survival time
(40.20 ± 0.31 days) as compared to the negative control
group (25.40 ± 0.43) while animals that received the
positive control diminazine aceturate had a mean sur-
vival time of 44.00 ± 0.63 days (Fig. 3).
The overall activities of the extracts are shown in Fig. 4.
The extracts had shown an increased values in the indi-
ces used for studying the potential of Verbascum sinaiti-
cum against Trypanosoma congolense infected mice. The
PVC and survival time had higher values as compared to
negative control.
Discussion
The Verbascum sinaiticum extracts showed an LD50
above 2000 mg/kg indicating there was no lethal effect.
The results validate why the plant has been used by sev-
eral traditional healers for treatment of various disease
including animal trypanosomiasis [21–24, 26], and toxicity
and antidotes have not been reported. The experimental
determination of this safety margin would justify that the
plant is safe at the dose levels used in this study, which is
an additional proof of the medicinal value of the plant in
folk medicine. Though in previous studies, phytochemi-
cals flavonolignans, hydrocarpin, sinaiticin, as well as two
flavones, chrysoeriol and luteolin from the leaf of V. sinai-
ticum exhibited dose-dependent cytotoxicity when tested
against cultured P-388 cells [44].
The trypanocidal and trypanostatic efficacy of V. sinaiti-
cum aqueous and methanol extracts are associated with the
presence of one or more biological active principals. This
was shown to be true by the positive test for the presence
of alkaloids, flavonoids, phenols, glycosides, saponins, ste-
roids, and tannins. Tatli et al. [45] reported that Verbascum
L. species has considerable saponins, iridoid and pheny-
lethanoid glycosides, monoterpene glucoside, neolignan
glucosides, flavonoids, steroids and spermine alkaloids that
are responsible for biological activities thus their use in folk
medicines. Previous in vitro and in vivo studies conducted
Table 2 The effect of aqueous and methanol leaf extracts of Verbascum sinaiticum on parasitaemia level of Trypanosoma congolense
infected mice
Days Parasitaemia level (log number/ml)
DA28 TW80 VSAE100 VSAE200 VSAE400 VSME100 VSME200 VSME400
Day0 7.68 + 0.18 7.44 + 0.17 7.32 + 0.07 7.08 + 0.07 7.31 + 0.11 7.44 + 0.11 7.08 + 0.15 7.32 + 0.12
Day2 0.00 + 0.00d*** 7.74 + 0.17 7.56 + 0.11 7.44 + 0.11 7.56 + 0.11 7.68 + 0.12 7.56 + 0.11 7.62 + 0.12
Day4 0.00 + 0.00d*** 7.86 + 0.11 7.50 + 0.09 7.80 + 0.13 7.32 + 0.07a**,c* 7.50 + 0.16 7.32 + 0.07a* 7.26 + 0.11a**
Day6 0.00 + 0.00d*** 8.16 + 0.11 d*** 7.32 + 0.00a*** 7.44 + 0.17a*** 7.14 + 0.11a*** 7.44 + 0.11a*** 7.02 + 0.07a***,b* 6.96 + 0.11a***,b*
Day8 0.00 + 0.00d*** 8.28 + 0.07d*** 7.44 + 0.06a*** 7.38 + 0.07a*** 6.78 + 0.12d*** 7.68 + 0.12a*** 6.66 + 0.06ab*** 6.54 + 0.11ab***
Day10 0.00 + 0.00d*** 8.52 + 0.12 d*** 7.74 + 0.11a*** 7.62 + 0.07a*** 7.08 + 0.12d*** 7.86 + 0.11a*** 7.14 + 0.11ab*** 6.36 + 0.17abc***
Day12 2.16 + 1.32d*** 8.64 + 0.06 8.04 + 0.11 7.92 + 0.12 7.56 + 0.11 7.98 + 0.07 7.44 + 0.11 6.72 + 0.20
Day14 5.52 + 0.07d*** 8.82 + 0.12 8.40 + 0.09 8.16 + 0.11a*** 8.04 + 0.11a*** 8.28 + 0.07a* 7.74 + 0.11a***,b* 7.20 + 0.16ab***,c*
Values are in Mean ± SEM; N = 5; DA28 diminazine aceturate 28 mg/kg-the positive control; VSAE V. sinaiticum aqueous extract; acompared to TW80 = 2 % tween
80-the negative control; bcompared to VSME 100 mg/kg; ccompared to VSAE 200 mg/kg; dcompared with all groups; *p < 0.05, **p < 0.01 and ***p < 0.001
Table 3 Effect of the aqueous and methanol leaf extracts of Verbascum sinaiticum on packed cell volume of Trypanosoma congolense
infected mice
Days PCV Values
DA28 TW80 VSAE100 VSAE200 VSAE400 VSME100 VSME200 VSME400
Pre-infection 51.18 ± 0.37 50.88 ± 0.14 51.38 ± 0.18 51.18 ± 0.24 51.44 ± 0.12 51.22 ± 0.19 51.30 ± 0.27 51.48 ± 0.23
Day 0 49.40 ± 0.23 49.04 ± 0.29 49.10 ± 0.19 49.18 ± 0.18 49.24 ± 0.16 49.20 ± 0.22 49.24 ± 0.17 48.88 ± 0.20
Day 7 48.88 ± 0.25d** 44.78 ± 0.37 44.78 ± 0.36 46.08 ± 0.32a*,b* 48.24 ± 0.18abc** 44.76 ± 0.27 47.40 ± 0.41ab** 47.56 ± 0.16 ab**
%change PCV
day 7–0
−1.05 −8.69 −8.79 −6.3 −2.03 −9.02 −3.73 −2.7
Day 14 50.08 ± 0.15d** 40.58 ± 0.27d** 43.72 ± 0.39a** 45.32 ± 0.37a**, b* 47.14 ± 0.25d** 44.30 ± 0.32 a** 46.80 ± 0.18 ab** 46.88 ± 0.35 ab**
% change PCV
day 7–14
2.45 −9.38 −2.36 −1.65 −2.28 −1.02 −1.09 −1.59
Values are expressed in Mean ± S.E.M; N = 5; DA28 diminazine aceturate 28 mg/kg- the positive control; VSAE V. sinaiticum aqueous extract; acompared to
TW80 = 2 % tween 80-the negative control; bcompared to VSAE 100 mg/kg; ccompared to VSAE 200 mg/kg; dcompared with all groups; *p < 0.05 and **p < 0.001
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on the antitrypanosomal activities of these phytochemicals
have reported the trypanocidal and trypanostatic potential
of these compound in human and animal trypanosomes
[14, 15, 46–48]. Therefore, the observed in vivo antitry-
panosomal activity of V. sinaiticum might be attributed
either to the individual class of compounds antitrypa-
nosomal activity or to the synergistic effect of each
class of compounds in the extracts [49].
The reduction of parasitaemia (6.36 + 0.17) and prolong-
ing of the lifespan (40.20 ± 0.31 days) of infected mice by a
higher dose of methanol extract can be associated to the
trypanosuppression of the phytochemical mainly the flavo-
noids that have been shown to exhibit potential to inhibit
the growth of African Trypanosomes [14, 50]. These bio-
logically active phytochemicals act at a single or multiple
target sites associated with a physiological process [14] and
interference with the redox balance of the parasites acting
on the respiratory chain or on the cellular defenses against
oxidative stress that partially eliminates the trypanosomes
[51, 52]. Moreover, the flavonoids compounds have
demonstrated promising antitrypanosomal activities on the
trypomastigote forms, which are usually found in the
bloodstream of mammalians [53, 54]. Alkaloids, flavonoids,
phenolics, and terpenes have shown trypanocidal activity
in an in vitro investigation, and the alkaloids have been
shown to reduce the growth of trypanosomes by intercalat-
ing in the deoxyribonucleic acid (DNA) of trypanosomes
[13] and inhibiting protein synthesis [53].
The trypanosomes are not eliminated from the blood
stream of infected mice though animals treated with
400 mg/kg methanol extract had significantly (p < 0.001)
lower mean parasitaemia (7.20 + 0.16) as compared to the
negative control group (8.82 + 0.12) on day 14 of treat-
ment. This result is similar to other studies conducted on
Khaya senegalensis [55], Artemisia abyssinica [56], Adan-
sonia digitata [18], Garcinia kola [57] and Carrisa edulis
[58] with antitrypanosomal activities. The efficacy of crude
extract might be masked with high parasite load in the
host animal [55, 59], or it could be due to enzymatic in-
activation of active compounds of the phytochemical in
the host animal and impaired absorption from the site of
administration [52, 60]. In addition, the concentration of
the phytochemicals that reaches the target organs, the
duration the phytochemicals take to effect a cure, and
short half-life of the phytochemicals can reduce the effi-
cacy of the crude extracts [61].
The effectiveness of diminazine aceturate was challenged
in all mice approximately on days 12–14 of treatment and
relapse of parasitaemia was observed [18]. T. congolense se-
quester in small vessels and capillaries of the heart, skeletal
and other tissues, which often leads to a prolonged pre-
patent period [62]. The relapse is also a clue to the ex-
istence of drug resistance trypanosomes in the South
West and North West part of the country since the
samples were acquired from the south-west part of
Ethiopia. The test organism obtained from south-west
part of Ethiopia can be a heterogeneous population of
trypanosomes that are sensitive and resistant to dimina-
zine aceturate; hence, the treatment with diminazine
aceturate could have eliminated the sensitive sub-
population through its therapeutic effects, so that the re-
lapse is the manifestation of resistant population [6, 7, 63].
The reduction in packed cell volume (PCV) observed
in extracts treated mice compared to diminazine aceturate
treated mice could be due to acute hemolysis induced by
the growing infection and increased susceptibility of red
blood cell membrane to oxidative damage [64]. A higher
PCV exhibited in mice treated with the extracts compared
with the negative control group might be as a result of the
phytochemicals reducing the parasite load, neutralizing
the toxic metabolites produced by trypanosomes; the
aetiological factors involved in the haemolysis of red blood






























Fig. 1 Comparison of the effect of aqueous and methanol leaf extracts




















Control and Experimental Groups
Fig. 2 Comparison of the effect of aqueous and methanol leaf
extracts of Verbascum sinaiticum on body weight of Trypanosoma
congolense infected mice
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radicals [59, 65, 66]. It could also be attributed to the
potential antioxidant activity of the flavonoids and gly-
cosides present in the leaf, which was also confirmed
by similar studies previously done on related plant spe-
cies from the same family [67–69].
The loss of body weight is associated with progression
of infection followed by appetite decreases, and the ani-
mal loses condition as a result, there is wasting. The de-
creased supply of oxygen because of the anemia is also
an important factor [70, 71]. However, animals, which
received 400 mg/kg aqueous and methanol extract of V.
sinaiticum gained weight by 1.07 and 1.67 % respectively,
which was statistically significant (p < 0.001) as compared
to the negative control groups. This shows that because of
reduction in parasitaemia and prevention of drop in PCV
as a result of the trypanosuppressive effect of the extracts
against trypanosome infection, physical status of the
treated mice was improved. Similar observations have
been made by other researchers [59, 68, 69, 72–74].
Conclusion
In vivo tests usually show reliable antitrypanosomal activ-
ities of traditional antitrypanosomal medicinal plants. V.
sinaiticum trypanocidal activity analysis indicated its
antitrypanosomal potential and without toxicity effect
on the host organism. The phytochemicals identified
are known to have antitrypanosomal activities. The
crude extracts have partially eliminated trypanosomes
in a dose-dependent manner. Though unintentional, this
study has also shown the existence of drug-resistant
trypanosomes in the field stock. The study has shown
that V. sinaiticum has a potential to be used as trypanocidal
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Fig. 4 Comparison of the effects of aqueous and methanol leaf extracts of Verbascum sinaiticum on parasitaemia, packed cell volume, body
weight, and survival time of Trypanosoma congolense infected mice at the end of the experimental study
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